Atlas Trials

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Clinical trial NCT07215234 · RECRUITING

Trial details

NCT number
NCT07215234
Sponsor
Sanofi
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Geographic Atrophy
Start date
2025-10-09
Primary completion
2027-10-13
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.